Literature DB >> 14023050

A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine.

S J CORNE, R W PICKERING, B T WARNER.   

Abstract

Injection of 5-hydroxytryptophan into mice produces a characteristic head-twitch. For a given period of observation this response may be assessed quantitatively either by observing the proportion of mice showing at least one head-twitch (a quantal response) or by counting the number of head-twitches for each mouse (a graded response). A method, based on the quantal response, of investigating the effect of centrally acting compounds on the head-twitch response is described. Evidence is presented that the head-twitches are due to a central action of 5-hydroxytryptamine formed by decarboxylation of 5-hydroxytryptophan. Head-twitches are potentiated by monoamine oxidase inhibitors and by phenytoin. Antagonists tested include an inhibitor of decarboxylase, antagonists of 5-hydroxytryptamine, some antihistamines, major tranquillizers and analgesic and sympathomimetic drugs. Drugs which neither potentiate nor inhibit the response include barbiturates and minor tranquillizers. The method may be valuable in the preliminary examination of compounds likely to have a central action.

Entities:  

Keywords:  ANALGESICS AND ANTIPYRETICS; ANTIHISTAMINICS; DIPHENYLHYDANTOIN; MONOAMINE OXIDASE INHIBITORS; SEROTONIN; SYMPATHOMIMETICS; TRANQUILIZING AGENTS

Mesh:

Substances:

Year:  1963        PMID: 14023050      PMCID: PMC1703746          DOI: 10.1111/j.1476-5381.1963.tb01302.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


  29 in total

1.  On the mechanism of antidepressant action of imipraminelike drugs.

Authors:  F SULSER; J WATTS; B B BRODIE
Journal:  Ann N Y Acad Sci       Date:  1962-01-13       Impact factor: 5.691

2.  Tryptamine receptors in the central nervous system.

Authors:  J R VANE; H O COLLIER; S J CORNE; E MARLEY; P B BRADLEY
Journal:  Nature       Date:  1961-09-09       Impact factor: 49.962

3.  In vivo monoamine oxidase inhibition measured by potentiation of tryptamine convulsions in rats.

Authors:  D H TEDESCHI; R E TEDESCHI; E J FELLOWS
Journal:  Proc Soc Exp Biol Med       Date:  1960-04

4.  [Jactatio capitis, a pharmacologically-produced motor stereotype in the mouse].

Authors:  G ZETLER; W MUELLER; I WARM
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1959

5.  5-hydroxytryptamine antagonists.

Authors:  L GYERMEK
Journal:  Pharmacol Rev       Date:  1961-09       Impact factor: 25.468

6.  Role of brain serotonin in reserpine action.

Authors:  P A SHORE; A PLETSCHER; E G TOMICH; A CARLSSON; R KUNTZMAN; B B BRODIE
Journal:  Ann N Y Acad Sci       Date:  1957-03-14       Impact factor: 5.691

7.  Clinical evaluation of BAS (benzyl analog of serotonin): a tranquilizing drug.

Authors:  L H RUDY; E COSTA; F RINALDI; H E HIMWICH
Journal:  J Nerv Ment Dis       Date:  1958-03       Impact factor: 2.254

8.  Identification and assay of serotonin in brain.

Authors:  D F BOGDANSKI; A PLETSCHER; B B BRODIE; S UNDENFRIEND
Journal:  J Pharmacol Exp Ther       Date:  1956-05       Impact factor: 4.030

9.  Some central actions of 5-hydroxytryptamine and various antagonists.

Authors:  J H GADDUM; M VOGT
Journal:  Br J Pharmacol Chemother       Date:  1956-06

10.  Drug-induced alterations in the sub-cellular distribution of 5-hydroxytryptamine in rats brain.

Authors:  S M SCHANBERG; N J GIARMAN
Journal:  Biochem Pharmacol       Date:  1962-03       Impact factor: 5.858

View more
  99 in total

1.  The effects of serotonergic and antiserotonergic drugs on the flexor reflex of spinal rat: a proposed model to evaluate the action on the central serotonin receptor.

Authors:  J Maj; W Palider; L Baran
Journal:  J Neural Transm       Date:  1976       Impact factor: 3.575

Review 2.  Serotonin receptor signaling and regulation via β-arrestins.

Authors:  Laura M Bohn; Cullen L Schmid
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-10-07       Impact factor: 8.250

3.  Serotonin, but not N-methyltryptamines, activates the serotonin 2A receptor via a ß-arrestin2/Src/Akt signaling complex in vivo.

Authors:  Cullen L Schmid; Laura M Bohn
Journal:  J Neurosci       Date:  2010-10-06       Impact factor: 6.167

4.  Response suppression induced with selective 5-HT agonists can be differentially blocked with LY53857 in an animal model of depression.

Authors:  E A Engleman; J M Murphy; F C Zhou; J N Hingtgen
Journal:  Neurochem Res       Date:  1992-05       Impact factor: 3.996

5.  A CONTROLLED CLINICAL TRIAL OF ALPHA METHYL DOPA IN PARKINSONIAN TREMOR.

Authors:  D O MARSH; H SCHNIEDEN; J MARSHALL
Journal:  J Neurol Neurosurg Psychiatry       Date:  1963-12       Impact factor: 10.154

6.  CENTRAL STIMULANT ACTIONS OF ALPHA-ALKYL SUBSTITUTED TRYPTAMINES IN MICE.

Authors:  A W LESSIN; R F LONG; M W PARKES
Journal:  Br J Pharmacol Chemother       Date:  1965-02

Review 7.  Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model.

Authors:  Clint E Canal; Drake Morgan
Journal:  Drug Test Anal       Date:  2012-04-19       Impact factor: 3.345

8.  Cocaine behavioral sensitization and the excitatory amino acids.

Authors:  R Karler; L D Calder; J B Bedingfield
Journal:  Psychopharmacology (Berl)       Date:  1994-07       Impact factor: 4.530

9.  Directly Observable Behavioral Effects of Lorcaserin in Rats.

Authors:  Katherine M Serafine; Kenner C Rice; Charles P France
Journal:  J Pharmacol Exp Ther       Date:  2015-09-17       Impact factor: 4.030

10.  Behavioral and 5-HT antagonist effects of ritanserin: a pure and selective antagonist of LSD discrimination in rat.

Authors:  F C Colpaert; T F Meert; C J Niemegeers; P A Janssen
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.